Natco Pharma Ltd.
NATCOPHARM
Natco Pharma is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). It is also engaged in contract manufacturing business, whereby it undertake selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.
Shareholding Pattern
| On | Ind. Pro. | Fore. Pro. | FII/FPI | Mutual Funds | Banks | Insurance | Others | Non/Institution |
|---|---|---|---|---|---|---|---|---|
| 2024-12 | 49.62 | 0 | 17.94 | 1.92 | 0 | 3.33 | 0.32 | 26.88 |
| 2024-09 | 49.62 | 0 | 17.51 | 2.37 | 0 | 4.23 | 0.15 | 26.12 |
| 2024-06 | 49.71 | 0 | 17.45 | 2.67 | 0 | 5.09 | 0.10 | 24.97 |
| 2024-03 | 49.71 | 0 | 16.14 | 4.08 | 0 | 5.58 | 0.04 | 24.46 |
| 2023-12 | 49.71 | 0 | 13.72 | 5.2 | 0 | 6.04 | 0.01 | 25.32 |
| 2023-09 | 49.71 | 0 | 12.82 | 7.65 | 0 | 6.34 | 0.02 | 23.46 |
| 2023-06 | 49.76 | 0 | 11.03 | 9.45 | 0.01 | 5.57 | 0.11 | 24.07 |
| 2023-03 | 48.84 | 0 | 11.91 | 8.5 | 0 | 6.42 | 0.45 | 23.87 |
| 2022-12 | 48.82 | 0 | 11.72 | 8.18 | 0.03 | 6.18 | 0.54 | 24.53 |
Results
| On | Income from Inv. | Int. on Bank Bal. | Int. on Advances | Other Int. | Interest Earned | Interest Exp. | Net Interest Income | Expenditure | Operating Income | Other Income | Prov. & Contingencies | PBT | Tax | PAT | Net Profit | Consolidated Net Profit | Adjusted EPS(Rs.) | Gross NPA | Gross NPA(%) | Net NPA | Net NPA(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09 | 0 | 0 | 0 | 0 | 1371.1 | 4.1 | 1367 | 566.8 | 868.1 | 63.8 | 0 | 818.2 | 141.7 | 676.5 | 676.5 | 677.3 | 37.84 | 0 | 0% | 0 | 0% |
| 2024-06 | 0 | 0 | 0 | 0 | 1362.6 | 5.2 | 1357.4 | 557.8 | 852.9 | 48.1 | 0 | 803.6 | 135.1 | 668.5 | 668.5 | 668.5 | 37.35 | 0 | 0% | 0 | 0% |
| 2024-03 | 0 | 0 | 0 | 0 | 1068.3 | 6.2 | 1062.1 | 571 | 539.3 | 42 | 0 | 477.6 | 91.3 | 386.3 | 386.3 | 386.3 | 21.58 | 0 | 0% | 0 | 0% |
| 2023-12 | 0 | 0 | 0 | 0 | 758.6 | 4.6 | 754 | 490.5 | 305.1 | 37 | 0 | 256.3 | 43.6 | 212.7 | 212.7 | 212.7 | 11.88 | 0 | 0% | 0 | 0% |
| 2023-09 | 0 | 0 | 0 | 0 | 1031.4 | 4.2 | 1027.2 | 573.4 | 487.4 | 29.4 | 0 | 439.6 | 70.6 | 369 | 369 | 369 | 20.61 | 0 | 0% | 0 | 0% |
| 2023-06 | 0 | 0 | 0 | 0 | 1140.5 | 4.2 | 1136.3 | 612.5 | 547.7 | 19.7 | 0 | 500 | 79.7 | 420.3 | 420.3 | 420.3 | 23.48 | 0 | 0% | 0 | 0% |
| 2023-03 | 0 | 0 | 0 | 0 | 897.9 | 2.7 | 895.2 | 558.8 | 368.1 | 29 | 0 | 324.4 | 48.6 | 275.8 | 275.8 | 275.8 | 15.11 | 0 | 0% | 0 | 0% |
| 2022-12 | 0 | 0 | 0 | 0 | 492.5 | 3.8 | 488.7 | 386.6 | 126.7 | 20.8 | 0 | 81.4 | 19.1 | 62.3 | 62.3 | 62.3 | 3.41 | 0 | 0% | 0 | 0% |
| 2022-09 | 0 | 0 | 0 | 0 | 432.1 | 3.8 | 428.3 | 336.8 | 115.8 | 20.5 | 0 | 70.3 | 13.5 | 56.8 | 56.8 | 56.8 | 3.11 | 0 | 0% | 0 | 0% |
| 2022-06 | 0 | 0 | 0 | 0 | 884.6 | 4.2 | 880.4 | 489.3 | 429.6 | 34.3 | 0 | 385.8 | 65.4 | 320.4 | 320.4 | 320.4 | 17.56 | 0 | 0% | 0 | 0% |